The nation of Zimbabwe has turned down a significant American health deal valued at 367 million US dollars (£272m) spanning five years over Washington's insistence on confidential information.
This move became public following a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
An official spokesperson later clarified that the US was demanding access to health data for scientific study and commercial gain but refused to share the benefits from future vaccines.
"We are forced to start the challenging and unfortunate task of ending our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had donated over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for further talks to secure a deal agreeable to both sides so the country's vital HIV programme can continue.
Broader Implications
This development follows a comparable situation in Kenya, where a court blocked a similar health funding agreement following legal challenges were raised about the safety of citizens' medical information.
Since returning to office recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump argued its spending was "wasteful" and his administration was seeking government-to-government deals to enhance openness and responsibility.
Based on statements, 16 African countries have to date agreed to similar agreements, representing over $18.3bn in committed funds.
Specifics of the Declined Deal
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration would have delivered extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy via US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Our nation was requested to surrender its genetic material and health information over an extended period, with no equivalent assurance of access to any scientific breakthroughs – such as new medicines or tests – that could result from that shared data," he stated.
"Effectively, our nation would supply the basic resources for medical research without any certainty that the final treatments would be accessible to our people should a new pandemic arise."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining systems previously established through the global organization.
The spokesperson cited its Pandemic Benefit-Sharing framework designed to manage potential global health emergencies.
"This framework is intended to ensure that when a nation provides its data, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," he added.
"We are open to further dialogue with our US partners on how subsequent co-operation might be arranged in a manner that respects the sovereignty and interests of both nations."
Medical Community Reaction
A leading public health body stated it recognised the official position, but suggested that talks need to persist since a large portion of the country's HIV programmes relied on foreign aid.
"Where technical issues arise, including those relating to information security or implementation frameworks, these can frequently be resolved through technical clarification and negotiated safeguards," it said.
The halted deal emphasises the complex debate between accepting much-needed international aid and protecting a country's data in an ever more data-driven world.